Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

31.34%

64.90%

41.67%

66.15%

Annual Dental Visits (ADV) Total

45.66%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

48.06%

46.74%

37.46%

48.16%

Appropriate Testing for Pharyngitis (CWP)

62.64%

77.56%

74.04%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

90.36%

93.08%

88.02%

91.27%

Asthma Medication Ratio (AMR) Total

57.69%

69.41%

67.34%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

62.96%

66.19%

64.80%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

52.80%

68.61%

56.45%

71.78%

Breast Cancer Screening (BCS)

47.30%

55.25%

Breast Cancer Screening (BCS-E)

47.23%

54.94%

49.36%

56.66%

Cervical Cancer Screening (CCS)

37.71%

59.85%

43.55%

60.10%

Childhood Immunization Status (CIS) Combination #10

25.33%

35.04%

18.25%

31.32%

Chlamydia Screening in Women (CHL) Total

58.06%

61.07%

57.51%

61.46%

Controlling High Blood Pressure (CBP)

39.66%

65.45%

57.66%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

75.30%

80.86%

76.74%

83.51%

Eye Exam for Patients With Diabetes (EED)

36.74%

56.20%

40.63%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

30.77%

27.73%

30.29%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

46.25%

46.35%

42.00%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

34.32%

41.03%

46.28%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

42.14%

37.31%

39.81%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

NA

57.90%

65.17%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

68.97%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

44.28%

55.72%

46.23%

59.64%

Immunizations for Adolescents (IMA) Combination #2

31.39%

38.93%

27.74%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

21.79%

16.94%

24.06%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

38.74%

38.80%

45.11%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

40.91%

39.01%

41.41%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

41.41%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

16.40%

31.93%

7.78%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

60.98%

75.79%

64.81%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

73.17%

86.96%

79.63%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

125.28%

≤ 92.72%

115.62%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

83.70%

86.86%

85.40%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

64.23%

80.78%

66.42%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

12.22%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

12.22%

25.81%

12.77%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

3.62%

≤ 2.45%

2.91%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

76.42%

81.64%

81.37%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

64.81%

73.63%

64.89%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

60.85%

67.07%

63.70%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

55.03%

70.37%

60.26%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

66.67%

63.89%

55.38%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

76.00%

75.44%

63.44%

72.74%

Use of Opioids at High Dosage (HDO)

1.55%

≤ 2.19%

2.24%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

1.60%

≤ 0.87%

1.93%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

59.37%

83.21%

79.32%

86.20%